Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CorticoMetrics is a private U.S. neurotechnology and software company developing quantitative tools to measure brain health and support neurological assessment. Its commercial Brain Gauge products use touch-based sensory testing to generate objective measurements of brain performance for clinic, sports, and at-home use. The company is also developing THINQ, a software-as-a-medical-device neuroimaging platform that derives brain morphometrics from MRI data to assist neuroradiologists and clinicians. CorticoMetrics appears to be focused on digital diagnostics and decision-support rather than therapeutics, with applications spanning concussion, traumatic brain injury, dementia, epilepsy, multiple sclerosis, hydrocephalus, ADHD, chronic pain, and related neurological conditions. The company was spun out of research conducted at the University of North Carolina and has received multiple U.S. SBIR/STTR awards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CorticoMetrics.